Log in  First Connection? Edition EN | FR

Archives   News of the month

 Japanese Encephalitis
Trends in temporal and spatial changes of Japanese encephalitis in Chinese Mainland, 2004-2019: a population-based surveillance study

Published on 18/02/2025 |  Original article (Abstract)  | Fu, Yun-Qiang et al. | Travel medicine and infectious disease 2024; 60(July–August 2024): 102724 4 min.

Japanese encephalitis (JE) is a serious health concern in China, with approximately 80% of global infections occurring in China. To develop effective prevention and control strategies, this study explored the epidemiological characteristics of JE in China based on spatiotemporal data, to understand the...

 Japanese Encephalitis
The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross‐sectional serosurvey

Published on 18/02/2025 |  Original article (Abstract)  | Zoe Baldwin et al. | The Medical journal of Australia 2024; 220(11): 561-5 4 min.

Japanese encephalitis virus (JEV) was first detected in New South Wales in February 2022. As few infections lead to clinical disease, estimating the number of infections in humans is difficult. The new: One in eleven serosurvey participants, drawn from five regional NSW towns deemed to be at risk on...

 Japanese Encephalitis
Japanese encephalitis virus infection causes reactive oxygen species‐mediated skeletal muscle damage

Published on 18/02/2025 |  Original article (Abstract)  | Gajendra Singh et al. | European Journal of Neuroscience 2024; 60(5): 4843-60 7 min.

Japanese encephalitis virus (JEV) annually infects a substantial population in the Asia‐Pacific region, particularly in rural and suburban areas (Baluni et al., 2018; Mulvey et al., 2021). Its primary impact is on children, leading to severe conditions such as meningoencephalomyelitis,...

 Japanese Encephalitis
Japanese encephalitis transmission in Australia: challenges and future perspectives

Published on 18/02/2025 |  Original article (Abstract)  | Caroline K Dowsett et al. | The Medical journal of Australia 2024; AOP: 10.5694/mja2.52550 3 min.

Japanese encephalitis is caused by the Japanese encephalitis virus (JEV). JEV is the main cause of viral encephalitis in Asia, and is endemic in many countries on that continent and islands of the Pacific region. Although only a small percentage of cases are symptomatic, 20–30% are fatal and 30–50%...

 Japanese Encephalitis
Effectiveness of Japanese encephalitis vaccination among children in central India

Published on 20/02/2024 |  Original article (Abstract)  | Babasaheb V. Tandale et al. | Journal of Medical Virology 2023; 95(1): 28399 3 min.

Japanese encephalitis (JE) is the main cause of acute encephalitis syndrome (AES) in South Asia, including India. There are 68 000 cases globally per year. Vector control is not so effective and difficult to implement. However, JE vaccination is reported to be an effective approach in various...